GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SS Innovations International Inc (OTCPK:SSII) » Definitions » Cash Conversion Cycle

SSII (SS Innovations International) Cash Conversion Cycle : 376.11 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is SS Innovations International Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

SS Innovations International's Days Sales Outstanding for the three months ended in Sep. 2024 was 100.95.
SS Innovations International's Days Inventory for the three months ended in Sep. 2024 was 344.57.
SS Innovations International's Days Payable for the three months ended in Sep. 2024 was 69.41.
Therefore, SS Innovations International's Cash Conversion Cycle (CCC) for the three months ended in Sep. 2024 was 376.11.


SS Innovations International Cash Conversion Cycle Historical Data

The historical data trend for SS Innovations International's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SS Innovations International Cash Conversion Cycle Chart

SS Innovations International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial - - - 241.39 306.90

SS Innovations International Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 212.66 359.23 246.68 235.90 376.11

Competitive Comparison of SS Innovations International's Cash Conversion Cycle

For the Medical Devices subindustry, SS Innovations International's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SS Innovations International's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where SS Innovations International's Cash Conversion Cycle falls into.


;
;

SS Innovations International Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

SS Innovations International's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=63.93+280.79-37.82
=306.90

SS Innovations International's Cash Conversion Cycle for the quarter that ended in Sep. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=100.95+344.57-69.41
=376.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SS Innovations International  (OTCPK:SSII) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


SS Innovations International Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of SS Innovations International's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


SS Innovations International Business Description

Traded in Other Exchanges
N/A
Address
Udyog Vihar, Phase III, 405, 3rd Floor, iLabs Info Technology Centre, Haryana, HR, IND, 122016
SS Innovations International Inc, formerly Avra Medical Robotics Inc develops medical-surgical devices. SSII's product range includes its proprietary SSi Mantra surgical robotic system and SSi Mudra, its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. It is a medical robotics company developing a fully autonomous medical robotic system using proprietary software which integrates Artificial Intelligence and Deep Learning, or machine learning. By using an AI and DL-enhanced software program, the company is creating an intelligent robotic system that it believes can robotize a wide range of medical procedures currently being performed by human hands. SSII's business operations are headquartered in India.
Executives
Sudhir Srivastava director, 10 percent owner, officer: Chairman and CEO C/O AVRA SURGICAL ROBOTICS, ONE LIBERTY PLAZA, 35TH FLOOR, NEW YORK NY 10006
Barry F Cohen director, officer: COO 1600 SOUTHEAST 15TH STREET, APT 512, FORT LAUDERDALE FL 33316
Kumar Sethi Anup officer: Chief Financial Officer C-102, DREAM APARTMENTS,, PLOT-14, SECTOR 22, DWARKA, NEW DEHLI K7 110077
Pascual Srivastava Vishwajyoti officer: President 28 HAARBAA, TRIAVENI GARDENS COMPLEX, GADAIPUR MEHRA, NEW DEHLI K7 110030
Sampige Prasannakumar Somashekar director APT 9J, NEST NO 8, 303 LG HALFI, RMV II, BANGALORE K7 560094
Annadurai Mylswamy director #344, NTI LAYOUT, 10TH MAIN, VIDHYARANYAPURA, BANGALORE K7 560067